Navigation Links
Advanced targeted therapies effective as first-line treatment for lung cancer
Date:8/1/2009

e West, Room 2001-2005, Level 2.

VANDETANIB PLUS DOCETAXEL VERSUS DOCETAXEL AS SECOND-LINE TREATMENT FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: A RANDOMIZED, DOUBLE-BLIND PHASE III TRIAL (ZODIAC) (ABSTRACT # C2.2)

Vandetanib is an orally administered medication that targets two receptors already known to play a role in non-small cell lung cancer (NSCLC) epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF). These receptors are targeted separately by other drugs, but vandetanib is the first drug designed to target both.

In previous research, the addition of vandetanib to chemotherapy was shown to prolong the progression-free survival (PFS) and improve response rate in patients with previously treated advanced NSCLC. To expand upon these findings, researchers conducted a phase III study to further evaluate whether vandetanib plus chemotherapy prolonged the PFS of advanced NSCLC patients when compared to chemotherapy alone.

Over two years, 1,391 patients were recruited to participate in the study. Patients were randomized to receive chemotherapy with vandetanib or chemotherapy with the placebo. A statistically significant difference in PFS was seen (HR = 0.79) in favor of vandetanib. The median PFS time was 17.3 weeks in the vandetanib arm versus 14 weeks in the control arm. While there was no statistical difference in overall survival, a significant improvement in objective response rate was observed. Vandetanib treatment was also associated with a statistically significant improvement in symptoms related to the underlying cancer.

"Clearly in a disease as heterogeneous as lung cancer, the need to target multiple pathways has become paramount. This agent, targeting two key pathways critical for non-small cell lung cancer growth and metastasis, is novel and could play a key role," said Roy S. Herbst, M.D., Ph.D., chief of thoracic medical oncology at the University of Texa
'/>"/>

Contact: Liz Wulderk
lwulderk@spectrumscience.com
443-506-1931
International Association for the Study of Lung Cancer
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Smith & Nephew Highlights Advanced Wound Management Progress
2. Patient safety advanced by revised heparin standards
3. AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer
4. Penile Prosthesis Surgery Infection Rates Reduced With The No-Touch Technique By Dr. J. Francois Eid of Advanced Urological Care
5. Leading Independent Analyst Firm States Silver Creek Systems Holds A Virtual Monopoly In Delivering Advanced Product Data Quality Capabilities
6. Surgery remans an option for advanced lung cancer
7. Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
8. Hendrick Health System Deploys Sentillions Tap & Go Advanced Authentication Solution
9. Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding DOXIL(R) for Treatment of Advanced Breast Cancer
10. Marienkrankenhaus Hamburg Installs Visage(R) CS Enterprise Wide Advanced Visualization Solutions
11. Advanced Bag Design for Cryopreservation: The New CryoMACS(R) Freezing Bag
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014 Youth Town’s annual BBQ/Music ... a.m. to 2 p.m. at the Youth Town campus ... World sponsors this family-oriented festival, which will offer music, ... will feature a car show, arts and crafts fair, ... children’s games. Also, Lightning McQueen and Mater from the ...
(Date:9/30/2014)... 30, 2014 Signet Puerto Rico, ... in San Juan, Puerto Rico, leverages RamSoft’s PowerServer ... , Nivia Souffront, site Administrator for Signet Puerto ... are excited to bring in PowerServer RIS/PACS/PM because ... care and physician satisfaction while reducing our costs ...
(Date:9/30/2014)... 30, 2014 Named a ‘Post ... Longmeadow facility has officially announced that they will ... that combines advanced medical technology with supportive, personalized ... of the only non-hospital options available in the ... The primary focus of this Ventilator Program is ...
(Date:9/30/2014)... 2014 Seniors Guide will take part ... race beginning in Raleigh, to support Alzheimer’s North Carolina ... and care. , Associate Publisher of Seniors Guide Magazine, ... senior resource for the Raleigh-Durham-Chapel Hill areas of North ... will be helping their team, “Eye of the Tiger”, ...
(Date:9/30/2014)... Employment website iHire ( http://www.ihire.com ) ... its marketing group, adding an experienced professional to ... their hiring needs within all of iHire’s niche ... sales and business development roles in traditional, digital, ... advertising. , With a wide-ranging career that has ...
Breaking Medicine News(10 mins):Health News:Signet Puerto Rico Leverages PowerServer RIS/PACS/PM™ to Improve Patient Care, Cut Costs 2Health News:Wingate Healthcare Announces New Ventilator Care Program at East Longmeadow Facility 2Health News:Wingate Healthcare Announces New Ventilator Care Program at East Longmeadow Facility 3Health News:Seniors Guide To Run in 203 Mile Alzheimer’s Awareness Relay in Raleigh, North Carolina 2Health News:Seniors Guide To Run in 203 Mile Alzheimer’s Awareness Relay in Raleigh, North Carolina 3Health News:iHire Expands Team With New Business Development Director 2
... Many of ... water scarcity have steep energy costs. , ... (PRWEB) June 17, 2010 -- This June award winning publication, IEEE Spectrum features ... water. According to a new special report in IEEE Spectrum magazine, the flagship monthly publication ...
... ... announce the addition of Lázaro Garza as an Engineered Sales Representative for Ellsworth Adhesives S. ... ... the addition of Lázaro Garza as an Engineered Sales Representative for Ellsworth Adhesives S. de ...
... is a great deal of interest in factors that contribute ... One factor that appears to contribute to the heritable ... codes for the serotonin transporter, also known as the serotonin ... transporter gene appears to increase one,s risk for depression and ...
... BOSTON (June 17, 2010) - Staying in shape may ... those with higher than desirable body fat percentages. In ... Nutrition Science and Policy at Tufts University found an ... metabolic risk factors that are precursors to cardiovascular disease ...
... ... like driving, especially those parents who live in areas where public transportation is limited or ... group in Walnut Creek and San Francisco to cope with this and many other dilemmas. ... Walnut Creek, CA (PRWEB) ...
... cancer treatment more likely to have variant, study shows ... identified a gene mutation that increases the risk of ... after surgery for early-stage breast cancer. , Tamoxifen is ... but previous studies have shown that it increases the ...
Cached Medicine News:Health News:Green Energy May Drain Our Water Supplies 2Health News:Green Energy May Drain Our Water Supplies 3Health News:Ellsworth Adhesives Announces New International Engineered Sales Representative 2Health News:PTSD: The serotonin system influences vulnerability and treatment 2Health News:Physical fitness may help reduce chronic disease risk in college students 2Health News:Support Group for Families Dealing with When to Take the Keys Away From Dad and Other Issues 2Health News:Support Group for Families Dealing with When to Take the Keys Away From Dad and Other Issues 3Health News:Support Group for Families Dealing with When to Take the Keys Away From Dad and Other Issues 4Health News:Gene Mutation Offers Clues to Tamoxifen-Blood Clot Link 2
(Date:9/29/2014)... PRINCETON N.J. , Sept. 29, 2014 /PRNewswire/ ... agents for medical imaging, has received a Drug ... Drug Administration for its assistance in preventing or ... being recognized for its efforts related to the ... the new drug application, submitting several post-approval supplements ...
(Date:9/29/2014)... -- Adaptive Biotechnologies, a clinical stage diagnostics company ... adaptive immune system, announced today that it has ... and clinical guidance for the implementation of its ... and monitoring of patients with leukemia and lymphoma. ... to support the utility of clonoSEQ TM , ...
(Date:9/29/2014)... Sept. 29, 2014 Raritan Bay Medical Center ... via Twitter, the social media website. Via Twitter, patients ... issues related to customer service by using the handle ... and its accessibility from any device makes it an ... serve its patients and community.  Raritan Bay Medical Center ...
Breaking Medicine Technology:Guerbet Receives FDA's Drug Shortage Assistance Award: Recognized for contributions to address a shortage of Ethiodol (ethiodized oil) injection 2Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board 2Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board 3@myrbmc: Healthcare Customer Service Support in 140 Characters or Less 2
... WASHINGTON, Oct. 21 Danaher Corporation (NYSE: DHR ... ended October 1, 2010 were $646.4 million, or $0.95 per ... formation of the Apex Tool Group joint venture, and represents ... diluted share of $0.53 for the third quarter 2009. On ...
... today announced the start of the Phase III ... inhibitor, S/GSK1349572 (,572). The Phase III clinical programme, ... and SAILING) that will evaluate ,572 in both ... "Progression of one of our lead ...
Cached Medicine Technology:Danaher Reports Record Third Quarter 2010 Results 2Danaher Reports Record Third Quarter 2010 Results 3Danaher Reports Record Third Quarter 2010 Results 4Danaher Reports Record Third Quarter 2010 Results 5Danaher Reports Record Third Quarter 2010 Results 6Danaher Reports Record Third Quarter 2010 Results 7Danaher Reports Record Third Quarter 2010 Results 8Danaher Reports Record Third Quarter 2010 Results 9Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor 2Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor 3Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor 4Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor 5
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: